Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 1998

View Archived Issues

rAAV vector to be evaluated for cardiovascular gene transfer

The role of dopamine D2 receptor in alcohol intake suppression

Elan announces completion of private placement for new company

Idec Pharmaceuticals: Q4 and FY 1997 highlights

CellCept evaluated in the clinic for another new indication

Phase III European trial results reinforce potential value of anti-LFA-1 MAb

Vical: Q4 and FY 1997 highlights

NanoSystems to develop new formulation of Boehringer Ingelheim drug

Transkaryotic Therapies: Q4 and FY 1997 highlights

IND approved for new formulation of lidocaine

Lead compounds identified in Warner-Lambert/Trega collaboration

Avigen: Q2 1998 highlights

New formulation of FK-506 demonstrates superior efficacy

Novel immunosuppressive extract magnifies the efficacy of ciclosporin in vitro

Immunosuppressive profile of activity of PS-64 extract

New GnRH antagonists from Merck & Co.

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Natural insulin secretagogue with potential in NIDDM

rhIL-11 sees first launch

First launch for Zenapax

Femara: second-line treatment option for advanced breast cancer

Bio-Technology General licenses hepatitis B vaccine

Effects of RX-871024 on Ca2+ evaluated in mouse pancreatic beta-cells

tPA associated with neurotoxic effects in acute model of stroke

SIDDCO expands combinatorial chemistry consortium

Therexsys acquires new technology and proposes new company name

Patients sought for GS-4104 clinical study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...